case_images: PMC5733994_01
case_images: Images showing left adrenal adenoma measuring 2.9 x 1.9 x 2.5 cm (shown in circles).
case_images: CRIE2017-6161348.001.jpg
case_images: PMC5733994_01_CRIE2017-6161348.001.jpg
case_images: fig1
case_images: A follow-up scan revealed a stable benign left adrenal adenoma (2.9 x 1.9 x 2.5 cm) measuring 14 Hounsfield units on noncontrast CT (Figure 1).
case_images: Change in blood pressure over time after initiating mifepristone treatment.  *Alternating daily doses of 600 and 900 mg.
case_images: CRIE2017-6161348.002.jpg
case_images: PMC5733994_01_CRIE2017-6161348.002.jpg
case_images: fig2
case_images: After 4 weeks, her antihypertensive medication (amlodipine/olmesartan medoxomil 10/20 mg) was discontinued and her blood pressure remained stable (Figure 2).
case_images: Change in liver enzymes over time after initiating mifepristone treatment. ALT, alanine transaminase; AST, aspartate transaminase; ULN, upper limit of normal.
case_images: CRIE2017-6161348.003.jpg
case_images: PMC5733994_01_CRIE2017-6161348.003.jpg
case_images: fig3
case_images: During the course of mifepristone treatment, she lost 16 lbs and marked improvement in her liver enzymes was noted, with complete normalization by week 20 (Figure 3).
case_images: Change in ACTH over time after initiating mifepristone treatment. ACTH, adrenocorticotropic hormone; LLN, lower limit of normal.
case_images: CRIE2017-6161348.004.jpg
case_images: PMC5733994_01_CRIE2017-6161348.004.jpg
case_images: fig4
case_images: During the 34-week course of medical therapy with mifepristone, the patient's hypothalamic-pituitary-adrenal (HPA) axis recovered, as indicated by increases in ACTH levels from undetectable at baseline and week 16 to 2.4 pmol/L at week 24 (Figure 4).